Table
of Contents
|
|
|
|
About the Author |
|
|
A Quarter Century of
AIDS and Counting: A Humanitarian Crisis |
|
|
AIDS UPDATE 2010 |
|
|
Preface |
|
Introduction |
Histories of Global
Pandemics, AIDS, Its Place in History, Overview of HIV/AIDS, International
AIDS Conferences and Means of Remembering—the AIDS Quilt, Candlelight
Memorial, and World AIDS Day |
|
|
Three
Words Echo around the World: AIDS Crisis Worsens! |
|
|
History
of Global Pandemics and Epidemics |
|
|
Fear,
Ignorance, and Condemnation: Who Is to Blame? |
|
|
Imagine
a World without AIDS |
|
|
Overview
of HIV/AIDS |
|
|
AIDS:
A Unique Disease |
|
|
AIDS:
A Cause of Death |
|
|
Another
Anniversary |
|
|
Other
Anniversaries |
|
|
International
AIDS Conferences |
|
|
Means
of Remembering |
|
|
The
27th Candlelight Memorial |
|
|
Walking
to Change the Course of the HIV/AIDS Epidemic—United States |
|
|
Bicycle
Riding to Change the Course of the HIV/AIDS Epidemic—United States |
|
|
World
AIDS Day: An International Day of Coordinated Action: A Time to Recharge and
Reconnect |
|
|
The
Future |
|
|
National
AIDS Hotlines |
|
|
Useful
Internet Addresses |
|
1 |
AIDS: Defining the
Disease and Finding its Cause |
|
|
The
New Millennium |
|
|
AIDS:
A Disease or a Syndrome? |
|
|
First
Reaction to AIDS: Denial |
|
|
What
Causes AIDS? |
|
|
The
Centers for Disease Control and Prevention Reports |
|
|
Discovery
of What Causes AIDS |
|
|
Defining
the Illness: AIDS and Surveillance |
|
|
Summary |
|
|
Review
Questions |
|
2 |
What Causes AIDS:
Origin of the AIDS Virus |
|
|
The
Cause of AIDS: The Human Immunodeficiency Virus (HIV) |
|
|
HIV
Does Not Cause AIDS: Dissidents and Their Cults: A Minority Point of View |
|
|
News
Flash 2010—Leading HIV/AIDS Dissident Cleared of Misconduct Following
Complaints Made After He and Others |
|
|
Published
a 2009 Paper Arguing That There Is “As Yet No Proof That HIV Causes AIDS” |
|
|
Dissidents
(AIDS Doesn’t Exist or HIV Isn’t the Cause) |
|
|
Summary
of HIV/AIDS Dissidents’ Viewpoints |
|
|
Evidence
that HIV Causes AIDS |
|
|
Origin
of HIV: The AIDS Virus |
|
|
Summary
on the Origin of HIV |
|
|
Summary |
|
|
Review
Questions |
|
3 |
Biological Characteristics
of HIV |
|
|
Viruses
Need a Host Cell in Order to Replicate |
|
|
Viruses
Are Parasites |
|
|
Viruses
Specific to Cell Type |
|
|
How Do
Human T4 or CD4+ Lymphocytes Relate to HIV Infection and AIDS? |
|
|
Description
of HIV; How It Attaches to a Host Cell and Buds Out of the Cell |
|
|
HIV
Fitness |
|
|
The
HIV Life Cycle |
|
|
Understanding
How HIV Works |
|
|
How
HIV Escapes the Infected Cell |
|
|
Distinct
Genotypes (Subtypes/Clades) of HIV-1 Worldwide
Based on ENV and GAG Proteins |
|
|
Summary |
|
|
Review
Questions |
|
4 |
Anti-HIV Therapy |
|
|
Better
Drugs, Better Technologies, and Lingering Problems |
|
|
Anti-HIV
Therapy |
|
|
The
Good News About ART |
|
|
Antiretroviral
Therapy (ART) Drugs with FDA Approval |
|
|
The
HIV Medicine Chest: ART Drugs Receiving FDA Approval |
|
|
FDA-Approved
Nucleoside/Non-Nucleoside Analog Reverse Transcriptase Inhibitors, Protease
Inhibitors, Integrase Inhibitors, |
|
|
Entry
Inhibitors, and Maturation Inhibitors |
|
|
Use of
Non-Nucleoside Analog Reverse Transcriptase Inhibitors |
|
|
FDA-Approved
Protease Inhibitors |
|
|
Entry Inhibitors
and Problems |
|
|
Integrase
Inhibitors |
|
|
Development
and Selection of HIV Drug-Resistant Mutants |
|
|
Development
of HIV Drug Resistance to Protease Inhibitors |
|
|
How
Combination Drug Therapy Can Reduce the Chance of HIV Drug Resistance |
|
|
Viral
Load: Its Relationship to HIV Disease and AIDS |
|
|
Medical
Complications Associated with Anti-HIV Drug Therapies (ART) |
|
|
Update
2010 |
|
|
Summary |
|
|
Disclaimer |
|
|
Some
AIDS Therapy Information Hotlines |
|
|
Review
Questions |
|
5 |
The Immunology of HIV
Disease/AIDS |
|
|
The
Immune System |
|
|
Human
Lymphocytes: T Cells and B Cells |
|
|
Why
CD4+ Cells Are Important in HIV Infection—What It Means |
|
|
The
CD4+ Cell Count—Why It Matters |
|
|
Antibodies
and HIV Disease |
|
|
Cellular
MicroRNAs Contribute to HIV Latency in Resting Primary
CD4+ T Cells |
|
|
Immune
System Dysfunction |
|
|
Original
Antigenic Sin |
|
|
The
Search for Additional Receptors (Coreceptors) to
CD4: Fusin or CXCKR-4 (R-4) |
|
|
CCKR-5
(R-5) Receptor |
|
|
Emergence
of HIV Strains That Vary in Their Lethal Abilities |
|
|
In Search
of Genetic Resistance to HIV Infection |
|
|
T4
Cell Depletion and Immune Suppression |
|
|
Impact
of T4 Cell Depletion |
|
|
Role
of Monocytes and Macrophages in HIV Infection |
|
|
Where
DO T4 or CD4+ Cells Become HIV Infected? |
|
|
Summary |
|
|
Review
Questions |
|
6 |
Opportunistic
Infections and Cancers Associated with HIV Disease/AIDS |
|
|
What
is an Opportunistic Disease? |
|
|
The
Prevalence of Opportunistic Diseases |
|
|
Opportunistic
Infections in HIV-Infected People |
|
|
TB:
The Leading Cause of Death among HIV-Positive People Worldwide |
|
|
Cancer
or Malignancy in HIV/AIDS Patients |
|
|
Disclaimer |
|
|
Summary
|
|
|
Review
Questions |
|
7 |
A Profile of Biological
Indicators for HIV Disease and Progression to AIDS |
|
|
What
Is Known and What Is Missing from Our Understanding of HIV/AIDS |
|
|
HIV
Disease Defined |
|
|
Stages
of HIV Disease (without Drug Therapy) |
|
|
HIV
Disease without Symptoms, with Symptoms, and AIDS |
|
|
Production
of HIV-Specific Antibodies |
|
|
Prognostic
Biological Markers Related to AIDS Progression |
|
|
HIV
Infection of the Central Nervous System (CNS) |
|
|
Neuropathies
(Nerve Tissue Damage) in HIV Disease/AIDS Patients |
|
|
Pediatric
Clinical Signs and Symptoms |
|
|
Summary |
|
|
Review
Questions |
|
8 |
Epidemiology and
Transmission of the Human Immunodeficiency Virus |
|
|
Epidemic/Epidemiology |
|
|
We
Must Stop HIV Transmission Now! |
|
|
Epidemiology
of HIV Infection |
|
|
Transmission
of Two Strains of HIV (HIV-1/HIV-2) |
|
|
IS HIV
Transmitted by Insects? |
|
|
HIV
Transmission |
|
|
HIV
Transmission in Family/Household Settings |
|
|
Noncasual Transmission |
|
|
Gay
Men Putting Themselves at High Risk for HIV Infection |
|
|
The
Biological Factor |
|
|
Injection-Drug
Users and HIV Transmission |
|
|
United
States: Heterosexual Injection-Drug Use (IDU) |
|
|
Injection-Drug
Use and HIV Infections in Other Countries |
|
|
Other
Means of HIV Transmission |
|
|
Influence
of Sexually Transmitted Diseases (STDs) on HIV Transmission and Vice-Versa |
|
|
Pediatric
Transmission |
|
|
Conclusion |
|
|
National
AIDS Resources |
|
|
Summary |
|
|
Challenge
Your Assumptions about the HIV Infected |
|
|
Review
Questions |
|
9 |
Preventing the
Transmission of HIV |
|
|
The
AIDS Generation: “I Knew Everything about It, and I Still Got It!” |
|
|
Prevention,
Not Treatment, Is the Least Expensive and Most Effective Way to Reduce the
Spread of HIV/AIDS |
|
|
Global
Prevention |
|
|
Antiretroviral
Drugs Have and Impact on Prevention, But We Can’t Treat Our Way Out of This
Pandemic |
|
|
Advancing
HIV Prevention: New Strategies for a Changing Epidemic |
|
|
Preventing
the Transmission of HIV |
|
|
Sexual
Risk Taking Depends on Sexual Activity |
|
|
New
Rules to an Old Game: Promoting Safer Sex—Nobody Has a Body to Die For! |
|
|
The
Male Condom |
|
|
The
Female Condom or Femidom (Vaginal Pouch) |
|
|
An
Alternative to Condoms: Vaginal Microbicides
(MI-CRO-BA-CIDES) and Circumcision |
|
|
Update
2010—The CAPRISA 004 Study Results |
|
|
Circumcision
and the Prevention of HIV Transmission |
|
|
Injection-Drug
Use (IDU) and HIV Transmission: The Twin Epidemics |
|
|
HIV
Prevention for Injection-Drug Users |
|
|
Prevention
of Blood and Blood Product HIV Transmission |
|
|
Infection
Control Procedures |
|
|
Sexual
Partner Notification: Disclosure |
|
|
The
U.S. Federal Government Has Now Adopted Partner Notification as Its
Cornerstone in Its Effort to Help Control the Spread of HIV |
|
|
The
First Human Vaccine: The Impact of Vaccines on Infectious Diseases |
|
|
HIV
Vaccine Development and Its Role in Prevention |
|
|
How
These Two Neutralizing Antibodies Work |
|
|
Types
of Experimental HIV Vaccines |
|
|
DNA
Vaccine |
|
|
Problems
in the Search for HIV Vaccine |
|
|
September
2009—News Broken that a Partially Effective HIV Vaccine Was Found! |
|
|
Summary |
|
|
Review
Questions |
|
10 |
Prevalence of HIV
Infections, AIDS Cases, and Deaths among Select Groups in the United States
and in Other Countries |
|
|
A Word
about HIV/AIDS Data |
|
|
Year
2011 |
|
|
Formula
for Estimating HIV Infections |
|
|
Behavioral
Risk Groups and Statistical Evaluation |
|
|
September
18: Annual National HIV/AIDS Aging Awareness Day |
|
|
Estimates
of AIDS Cases and HIV Infection |
|
|
Newly
Infected |
|
|
Shape
of the HIV Pandemic: United States |
|
|
Estimates
of Deaths and Years of Potential Life Lost Due to AIDS in the United States |
|
|
Selected
Nations/Countries Have Different Epidemics. Each Faces Its Own Reality |
|
|
Canada’s
Estimated HIV/AIDS Cases through 2009: Population 110 Million |
|
|
United
Kingdom’s (UK) Estimated HIV/AIDS Cases through 2009: Population 61 Million |
|
|
Global
Prevalence and Impact of HIV/AIDS |
|
|
Connected
but Separate: Each Country a Different Reality, Different Countries, Similar
Questions, but Different Answers, |
|
|
Different
Epidemics |
|
|
Workforce—South
Africa: Some Examples |
|
|
Education:
Teachers and Students—South Africa and Some Countries in Southern Africa |
|
|
Other
HIV/AIDS Time Bombs in Asia: India, China, and Russia |
|
|
Summary |
|
|
Review
Questions |
|
11 |
Prevalence of HIV Infection
and AIDS Cases among Women and Children |
|
|
HIV/AIDS
Is Defining the Lives of Millions of Women |
|
|
Female
Vulnerability to HIV |
|
|
Every
Day a Tragedy |
|
|
Triple
Jeopardy |
|
|
Annual
International Women’s Day—March 8 |
|
|
Women:
AIDS and HIV Infections Worldwide |
|
|
Asia-Pacific
Region, Over Five Million HIV Positive: 2010 |
|
|
Women:
HIV-Positive and AIDS Cases—United States |
|
|
Childbearing
Women: Worldwide |
|
|
Internet
Resources |
|
|
Pediatric
HIV-Positive and AIDS Cases—United States: A Fight We Can Win! |
|
|
Orphaned
Children Due to HIV Infection and AIDS |
|
|
The
Phenomenon of AIDS Orphans |
|
|
Summary |
|
|
Review
Questions |
|
12 |
Prevalence of HIV
Infection and AIDS among Young Adults, Ages 13 to 24 |
|
|
Global
HIV Infections in Young Adults |
|
|
Addressing
the AIDS Pandemic among Young Adults |
|
|
How
Large Is the Young Adult Population in the United States? |
|
|
HIV/AIDS
Won’t Affect Us! |
|
|
Estimate
of HIV-Infected and AIDS Cases among Young Adults in the United States,
Globally |
|
|
Summary |
|
|
Internet |
|
|
Other
Useful Sources |
|
|
Review
Questions |
|
13 |
Testing for Human
Immunodeficiency Virus |
|
|
Determining
the Presence of Antibody Produced When HIV Is Present |
|
|
Requests
for HIV Testing |
|
|
Reasons
for HIV Testing: I Know, I Took the Test |
|
|
Laboratory
Methods for Detecting HIV |
|
|
ELISA
HIV Antibody Test |
|
|
Western
Blot Assay |
|
|
New
ELISA Antibody Testing and Viral Load Procedures Reveal Early Versus Late HIV
Infection |
|
|
Rapid
Result HIV Testing |
|
|
FDA
Approves Home HIV Antibody Test Kit |
|
|
Some
Screening and Confirmatory Antigen-Detection Tests for HIV |
|
|
Deciding
Who Should Get an HIV Test and When |
|
|
Why Is
HIV Test Information Necessary? |
|
|
Immigration
and Travel Ban into the United States Is Lifted |
|
|
Testing,
Privacy, Competency, and Informed Consent |
|
|
Summary |
|
|
Review
Questions |
|
14 |
AIDS and Society:
Knowledge, Attitudes, and Behavior |
|
|
HIV/AIDS
Is a Story in Our Lifetime |
|
|
The
New Millennium and HIV/AIDS |
|
|
HIV/AIDS
Is an Unusual Social Disease |
|
|
Discrimination
vs. Compassion and Support |
|
|
HIV/AIDS
Is Here to Stay |
|
|
AIDS
Comes to the United States |
|
|
Blame
Someone, Déjà Vu |
|
|
Fear:
Panic and Hysteria over the Spread of HIV/AIDS in the United States |
|
|
Whom Is
the General Public to Believe? |
|
|
AIDS
Education and Behavior: Dissipating Fear with Education |
|
|
The Character
of Society |
|
|
Dealing
with Discrimination: The Americans with Disabilities Act |
|
|
Federal
and Private Sector Financing: Creation of an AIDS Industry |
|
|
U.S.
Government Believes HIV/AIDS Is a Threat to National Security |
|
|
Global
HIV/AIDS Funding for Underdeveloped Nations |
|
|
Forms
of U.S. Monetary Assistance for HIV/AIDS |
|
|
Summary |
|
|
Review
Questions |
|
|
Answers to Review
Questions |
|
|
Glossary |
|
|
References |
|
|
Index |
|
|
|
|